dpp 4 and glp 1 together Mechanisms of beneficial effects of increased-based therapy. Dipeptidyl DPP-4 inhibitors and GLP-1RAs: cardiovascular

Will a plateau be reached

Cell Rep Med 4(11) Dankner R, Murad H, Agay N, Olmer L, Freedman LS (2024) Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes

Some studies have shown that GLP-1RAs act on the hypothalamus to promote satiety and reduce food intake, inhibit gastric emptying [52], thereby leading to weight loss and potentially improving upper airway collapsibility

But, as she says, 'it didn't change the fact that nothing worked.' Following this Knudsen got roped into the team's effort to improve a native GLP-1 peptide licensed from MGH

A therapy that works well until the body adapts